AI Article Synopsis
- The study investigates the long-term sexual dysfunction associated with serotonin reuptake inhibitors, finasteride, and isotretinoin, collecting data from 120 reports from RxISK.org.* -
- Findings indicate that these three drugs share a similar range of symptoms experienced by both men and women, regardless of their geographic location.* -
- The research highlights the seriousness of this enduring condition, emphasizing the need for further understanding of its causes and effective treatment options.*
Article Abstract
Background: There have been reports for over a decade linking serotonin reuptake inhibitors, finasteride and isotretinoin with enduring sexual dysfunction after treatment stops.
Objective: To explore the clinical pictures linked to all 3 drugs.
Methods: We have selected 120 reports to RxISK.org reporting the problem and mined these for data on age, gender, drug of use, and impact of the problem.
Results: The data make it clear that the three drugs show extensive overlap in symptom profile, regardless of sex or country of origin.
Conclusions: The availability of 120 reports from over 20 countries add to the case for the validity of the syndrome. This is severe and enduring condition can result in death. An understanding of its physiology and an approach to treatment are needed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3233/JRS-140617 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!